Next-generation sequencing in pharmacogenomics – fit for clinical decision support?

Yitian Zhou,Volker M. Lauschke
DOI: https://doi.org/10.1080/17512433.2024.2307418
2024-01-25
Expert Review of Clinical Pharmacology
Abstract:Introduction The technological advances of sequencing methods during the past 20 years have fuelled the generation of large amounts of sequencing data that comprise common variations, as well as millions of rare and personal variants that would not be identified by conventional genotyping. While comprehensive sequencing is technically feasible, its clinical utility for guiding personalized treatment decisions remains controversial.
pharmacology & pharmacy
What problem does this paper attempt to address?